Results 141 to 150 of about 1,715,615 (239)
FLCN Multi‐Exon Deletion in a Chihuahua With Renal Cysts and Nodular Dermatofibrosis
Animal Genetics, Volume 57, Issue 5, October 2026.
Melvin Schneiter +6 more
wiley +1 more source
The ‘Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease’ (PATROL) study
BJU International, Volume 138, Issue 4, Page 600-606, October 2026.Background Inherited (germline) pathogenic and likely pathogenic variants (gPVs) in key genes associated with increased risk of prostate cancer (PCa) now warrant more attentive PCa screening per National Comprehensive Cancer Network (NCCN) guidelines—e.g., BRCA2, HOXB13, ATM, BRCA1, MSH2, MSH6, CHEK2 and TP53.
Heather H. Cheng +12 more
wiley +1 more source
The evolving role of immunotherapy in ovarian cancer
Cancer, Volume 132, Issue 18, 15 September 2026.Abstract Ovarian cancer remains a major cause of gynecologic cancer mortality; and, although immune checkpoint inhibitors have transformed treatment in other solid tumors, their activity in ovarian cancer has been limited by tumor heterogeneity, an immunosuppressive tumor microenvironment, and the lack of robust predictive biomarkers.
Ana Carolina Veneziani +2 more
wiley +1 more source
BRCA2: a grown-up cancer susceptibility gene [PDF]
Endocrine-Related Cancer, 2016 William D, Foulkes, Kokichi, Sugano
openaire +2 more sources
Revista Colombiana de Obstetricia y Ginecología, 2015 Objetivo: describir variantes de secuencia en los genes BRCA1 y BRCA2 en una muestra de pacientes colombianas con historia personal o familiar de cáncer de mama sugestiva de riesgo genético. Materiales y métodos: serie de casos compuesta por 67 pacientes
Juan Felipe Arias-Blanco +9 more
doaj
The Significance of Somatic Variants Involved in the Development of Pancreatic Cancer in Patients with HBOC-Associated Germline Variants. [PDF]
Genes (Basel)Uchiyama K +9 more
europepmc +1 more source